Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jonnala, Ujwal Kumar"'
Publikováno v:
In BBA - Molecular Cell Research August 2020 1867(8)
Autor:
Jonnala Ujwal Kumar, Vaidyanathan Subramaniam, Upasana Sarangi, Khande Rao Paithankar, Amere Subbarao Sreedhar
Publikováno v:
Drug Target Insights, Vol 2012, Iss 6, Pp 19-39 (2012)
Externí odkaz:
https://doaj.org/article/33d62116d7814a70915904523efc4218
Autor:
Chaturvedi Vishal, Jonnala Ujwal Kumar, Cherukuvada Veera Brahmendra Swamy, Rangaraj Nandini, Gunda Srinivas, Rathinam Kumaresan, Singh Shashi, Amere Subbarao Sreedhar
Publikováno v:
Drug Target Insights, Vol 2011, Iss 5, Pp 11-32 (2011)
Externí odkaz:
https://doaj.org/article/f2c306a38fda4abb9bde9c8d8e26c3eb
Autor:
Upasana Sarangi, Khande Rao Paithankar, Jonnala Ujwal Kumar, Vaidyanathan Subramaniam, Amere Subbarao Sreedhar
Publikováno v:
Drug Target Insights, Vol 6, Iss 1 (2012)
Abstract non disponibile
Externí odkaz:
https://doaj.org/article/ad34e5111ce346c1b4152cad04b6fd71
Autor:
Upasana Sarangi, Khande Rao Paithankar, Jonnala Ujwal Kumar, Vaidyanathan Subramaniam, Amere Subbarao Sreedhar
Publikováno v:
Drug Target Insights, Vol 6 (2012)
Hsp90 chaperone has been identified as an attractive pharmacological target to combat cancer. However, some metastatic tumors either fail to respond to Hsp90 inhibition or show recovery necessitating irreversible therapeutic strategies. In response t
Externí odkaz:
https://doaj.org/article/a1bf29bec2bc4e16a2e606fc8d0e040c
Autor:
Chaturvedi Vishal, Jonnala Ujwal Kumar, Cherukuvada Veera Brahmendra Swamy, Rangaraj Nandini, Gunda Srinivas, Rathinam Kumaresan, Singh Shashi, Amere Subbarao Sreedhar
Publikováno v:
Drug Target Insights, Vol 5, Iss 1 (2011)
Abstract non disponibile
Externí odkaz:
https://doaj.org/article/9b73b0838b284cf68e490c7e40393523
Autor:
Jonnala Ujwal Kumar, Lebaka Prasanna Anjaneya Reddy, Amere Subbarao Sreedhar, Upasana Sarangi, Pitke Vikrant Vinay, Sugunan Sreedevi
Publikováno v:
Journal of Cancer Therapy. :709-719
Mitosis-targeted anti-cancer therapies gained much attention in recent years. However, lack of tumor selectivity poses limitations to the current anti-mitotic drugs to be used as broad-spectrum anti-cancer agents. In this study, we show that combinat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df15fab7bdc1faf0eead5ef65edb8d73
https://doi.org/10.4236/jct.2013.43087
https://doi.org/10.4236/jct.2013.43087
Autor:
Amere Subbarao Sreedhar, Jonnala Ujwal Kumar, Perumal Vanathi, Khanderao Paithankar, Vishal Chaturvedi
Publikováno v:
Medicinal chemistry (Shariqah (United Arab Emirates)). 7(5)
Pharmacological inhibition of Hsp90 in tumor cells induces anticancer effects through the destabilization of several oncogenic signaling molecules. Although there were reports that Hsp90 inhibition compromises cellular integrity, how this affects the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d3e728f21d1f571fd4195292e69808e
https://pubmed.ncbi.nlm.nih.gov/21801149
https://pubmed.ncbi.nlm.nih.gov/21801149